A Phase I Dose Escalation Trial of Afatinib Plus Gemcitabine or Plus Docetaxel
Clinical trial NCT01251653 · COMPLETED
Trial details
- NCT number
- NCT01251653
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-11-01
- Primary completion
- 2015-04-01
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.